Is There a Role for Thromboprophylaxis in Selected Outpatients With COVID-19?
Sign Up to like & getrecommendations! Published in 2022 at "JAMA internal medicine"
DOI: 10.1001/jamainternmed.2022.5878
Abstract: Is There a Role for Thromboprophylaxis in Selected Outpatients With COVID-19? To the Editor Mr Xie and colleagues1 provide important information on an understudied topic: incident venous thromboembolism (VTE) in outpatients with COVID-19. The findings… read more here.
Keywords: selected outpatients; thromboprophylaxis; vte risk; risk ... See more keywords
Assessment of the Risk of Venous Thromboembolism in Nonhospitalized Patients With COVID-19
Sign Up to like & getrecommendations! Published in 2023 at "JAMA Network Open"
DOI: 10.1001/jamanetworkopen.2023.2338
Abstract: Key Points Question What is the risk of venous thromboembolism (VTE) among outpatients with COVID-19? Findings In this cohort study of 398 530 adult outpatients with COVID-19, the rate of VTE was low in the first… read more here.
Keywords: venous thromboembolism; vte; risk; risk venous ... See more keywords
Genetics of symptom remission in outpatients with COVID-19
Sign Up to like & getrecommendations! Published in 2021 at "Scientific Reports"
DOI: 10.1038/s41598-021-90365-6
Abstract: We conducted a genome-wide association study of time to remission of COVID-19 symptoms in 1723 outpatients with at least one risk factor for disease severity from the COLCORONA clinical trial. We found a significant association… read more here.
Keywords: outpatients covid; genetics symptom; remission; symptom remission ... See more keywords
Chilblain‐like lesions in pediatrics dermatological outpatients during the COVID‐19 outbreak
Sign Up to like & getrecommendations! Published in 2020 at "Dermatologic Therapy"
DOI: 10.1111/dth.13516
Abstract: In Spain, with full confinement measures and coinciding with the pandemic, pediatricians and dermatologists have received, through teledermatology/teleconsultation and social networks, a barrage of diverse images, which have subsequently allowed us to approach some of… read more here.
Keywords: outpatients covid; chilblain like; like lesions; pediatrics dermatological ... See more keywords
Casirivimab and imdevimab: Cost-effectiveness analysis of the treatment based on monoclonal antibodies on outpatients with Covid-19
Sign Up to like & getrecommendations! Published in 2023 at "PLOS ONE"
DOI: 10.1371/journal.pone.0279022
Abstract: Background and objectives In 2020, the world was profoundly affected by the spread of SARS-CoV-2, a novel coronavirus first identified in December 2019, that was the causative agent of coronavirus disease 2019 (Covid-19), a severe… read more here.
Keywords: casirivimab imdevimab; treatment; cost; outpatients covid ... See more keywords
In high-risk outpatients with COVID-19, neither colchicine nor aspirin reduced disease progression or death at 45 d
Sign Up to like & getrecommendations! Published in 2023 at "Annals of Internal Medicine"
DOI: 10.7326/j22-0118
Abstract: SOURCE CITATION Eikelboom JW, Jolly SS, Belley-Cote EP, et al. Colchicine and aspirin in community patients with COVID-19 (ACT): an open-label, factorial, randomised, controlled trial. Lancet Respir Med. 2022;10:1160-8. 36228639. read more here.
Keywords: covid neither; risk outpatients; high risk; colchicine ... See more keywords